Target- |
MechanismBacteria replacements [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date01 Jan 2009 |
100 Clinical Results associated with ISEI Co., Inc.
0 Patents (Medical) associated with ISEI Co., Inc.
100 Deals associated with ISEI Co., Inc.
100 Translational Medicine associated with ISEI Co., Inc.